logo of the EU drugs agency

You are viewing archived content

Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the EMCDDA.

Figure PDU-1. Estimates of the prevalence of problem drug use (rate per 1 000 population aged 15 to 64), 2005 to 2010 — last study available

Part (ii) Estimates of problem opioid use

statistical graphic
CountryYearMethodLabelLowHighCentral
Related links:
Turkey2010MMTurkey 2010 MM0.30.710.34
Hungary2007/08CRHungary 2007/08 CR0.400.500.45
Poland2005OTPoland 2005 OT0.931.081.01
Cyprus2010TPCyprus 2010 TP1.021.321.14
Finland2005CRFinland 2005 CR1.11.41.2
Slovakia2008OTSlovakia 2008 OT1.012.491.25
Czech Rep.2010TMCzech Rep. 2010 TM1.401.561.48
Netherlands2008TMNetherlands 2008 TM1.561.641.60
Germany*2009TMGermany* 2009 TM1.762.091.93
Lithuania2007CRLithuania 2007 CR2.292.422.36
Greece2010CRGreece 2010 CR2.683.342.99
Norway2008CMNorway 2008 CM2.13.93
Croatia2010CRCroatia 2010 CR3.233.993.61
Austria2009CRAustria 2009 CR4.404.734.57
Italy2010TMItaly 2010 TM4.975.835.51
Luxembourg2007OTLuxembourg 2007 OT57.65.9
Malta2010CRMalta 2010 CR5.686.546.07
Latvia2010TMLatvia 2010 TM6.6
Ireland2006CRIreland 2006 CR6.28.17.2
Statistical bulletin 2012: https://www.emcdda.europa.eu/stats12/pdufig1b
For more details see https://www.emcdda.europa.eu/stats12/pdu/tables (Tables PDU-1 and PDU-102) in the Statistical bulletin 2012.
See also https://www.emcdda.europa.eu/html.cfm/index1372EN.html: National prevalence estimates of problem drug use in the European Union, 1995–2000, CT.00.RTX.23, EMCDDA, Lisbon, coordinated by the Institut für Therapieforschung, Munich.
See also ‘General notes for interpreting data’ on the Explanatory notes and help page

Notes:

Methods of estimation are abbreviated: CR=Capture-recapture; TM =Treatment multiplier; PM = Police multiplier; MI = Multivariate indicator; TP= Truncated Poisson; CM = Combined methods; MM= Mortality multiplier; OT= Other methods.

Germany reported more than one estimate. For full details see Table PDU-102

In the case of Finland, the original age range of the study is 15 to 54 years old. Rates were ajusted for ages 15 to 64.

Target groups may vary slightly between countries owing to different methods and data sources; therefore comparisons should be made with caution.

The symbol indicates a point estimate, a bar indicates an uncertainty interval, which can be either a 95 % confidence interval or an interval based on sensitivity analysis.

Sources:

AAA BBB CCC
X 2 3 4
1 2 3 4
X 2 3 4
1 2 3 4
X 2 3 4
1 2 3 4

abcfigN

 

Page last updated: Tuesday, 17 July 2012